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The complex sheep cervical structure has been an obstacle to uterine access and to non-surgical embryo 
collection by transcervical route. Thus, hormonal protocols aiming at the relaxation of the cervix become 
important for the development of this technique. However, the hormonal environment of embryo donors 
needs to be compatible with embryo formation, and little is known about the effect of hormones used in 
the cervix dilatation protocols on progesterone (P4) concentration, as well as on embryo development and 
quality (EQ). Thus, this study aimed to evaluate the influence of a hormonal protocol of cervical 
dilatation, on the P4 serum concentration, stages of development and EQ. For this, 40 Santa Inês sheep 
were submitted to day zero protocol (Pinto P et al., 2018. Theriogenology, 113: 146-152) followed by 
natural mating. The animals were allocated into: treated group (Treat; n = 20), which consisted in 
administrati , i.v.) and cloprostenol (0.12 mg, i.m.) 12 h prior to embryo 
collection associated with the application of oxytocin (100 IU, i.v.) 15 min prior to collection procedure 
(Leite L et al. Arq Bras Med Vet Zootec, 70:1671-1679); the other group was the control (Cont; n = 20), 
with saline administration. All embryos were collected by laparotomy and classified according to criteria 
established by the IETS. Blood samples were collected prior to protocol (dilation or control; 0 h), 3 h, 6 h, 
9 h, and 12 h after hormone or saline administration. Serum was used for the P4 measurement by 
radioimmunoassay. Data were tested for normality and homoscedasticity with the Lilliefors and Bartlett's 
tests, respectively. P4 concentrations were compared by paired ANOVA followed by t test (normal data), 
and by the Mann Whitney or Friedman test for non-parametric data. Embryo data were evaluated by 
Fisher's test, all with a significance level of 5%. The control group had a tendency to a higher total 
number of embryos recovered per female (Treat: 3.8 ± 3.6 vs. Cont: 5.4 ± 2.7; P = 0.058). For the viable 
embryos by female, the control group (3.4 ± 2.4) was superior (P < 0.05) when compared to the treated 
group (2.0 ± 2.9). Regarding the frequency distribution at each stage of development, there were no 
differences between groups (P > 0.05). In each grade of EQ there was an uniform distribution between the 
groups (Grade I Treat: 46.8 vs. Cont: 57.1; Grade II Treat: 38.3 vs. Cont: 33.3; Grade III Treat: 8.5 vs. 
Cont: 7.9; Grade IV Treat: 6.4 vs. Cont: 1.6, P > 0.05). However, analysis restricted in control group, 
obtained a higher frequency of grade I embryos (P < 0.05), while in the treated group prevailed grade I and 
II (P < 0.05). Serum concentrations of P4 at 0 h were Treat: 10.54 ± 10.03 vs. Cont: 8.54 ± 6.20; P > 0.05. 
The control group had higher concentrations compared to treated at 6 h (Treat: 3.70 ± 3.29 vs. Cont: 
9.22 ± 5.73 ng/mL), 9 h (Treat 2.24 ± 2 01 vs. Cont: 9.11 ± 6.56 ng/mL) and 12 h (Treat 1.92 ± 1.69 vs. 
Cont: 11.57 ± 7.22 ng/mL) after protocol or saline administration (P < 0.05). In the control group, P4 
concentrations did not differ during the evaluations (P > 0.05), whereas in the treated group there was a 
decrease from 6 h to 12 h after the protocol (P < 0.05). Thus, we can conclude that cervical dilation 
hormonal protocol promotes a drop in P4 concentrations after 6 h of administration, although it does not 
affect the development of ovine embryos. 
Support: EMBRAPA (Project 02.13.06.026.00.03) and CNPq (400785/2016-1). 
 
Keywords: cervix, embryo collection, hormonal dosage, embryonic quality, sheep. 
Palavras-chave: cérvix, coleta de embrião, dosagem hormonal, qualidade embrionária, ovelhas.  
